NDC 0071-0525

Celontin

Methsuximide

Celontin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Parke-davis Div Of Pfizer Inc. The primary component is Methsuximide.

• Product ID: 0071-0525_aae60e0d-e70b-44b4-8d19-3411f359a00a
• NDC: 0071-0525
• Product Type: Human Prescription Drug
• Proprietary Name: Celontin
• Generic Name: Methsuximide
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 1957-02-08
• Marketing Category: NDA / NDA
• Application Number: NDA010596
• Labeler Name: Parke-Davis Div of Pfizer Inc
• Substance Name: METHSUXIMIDE
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0071-0525-24

100 CAPSULE in 1 BOTTLE (0071-0525-24)

• Marketing Start Date: 1957-02-08
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0071-0525-24 [00071052524]

Celontin CAPSULE

• Marketing Category: NDA
• Application Number: NDA010596
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1957-02-08

Drug Details

Active Ingredients

Ingredient	Strength
METHSUXIMIDE	300 mg/1

OpenFDA Data

• SPL SET ID: 64a6ee88-c6b1-4e13-8208-b6772ef65a74
• Manufacturer:
  • Parke-Davis Div of Pfizer Inc
• UNII:
  • 0G76K8X6C0
• RxNorm Concept Unique ID - RxCUI:
  • 197949
  • 207088

Pharmacological Class

• Anti-epileptic Agent [EPC]
• Decreased Central Nervous System Disorganized Electrical Activity [PE]
• Anti-epileptic Agent [EPC]
• Decreased Central Nervous System Disorganized Electrical Activity [PE]

NDC Crossover Matching brand name "Celontin" or generic name "Methsuximide"

NDC	Brand Name	Generic Name
0071-0525	Celontin	methsuximide
24822-525	Celontin	METHSUXIMIDE